Here’s how much people are willing to spend on weight loss drugs, according to a new survey
Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly
Read MoreSome patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly
Read MoreMedicare patients can soon get coverage for Novo Nordisk's Wegovy as long as it is prescribed to reduce their risk
Read MoreSome health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read MoreThe FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are
Read MoreAmazon Pharmacy second online pharmacy to partner with Eli Lilly's site, and could provide faster deliveries for certain patients. Source
Read MoreThe pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Read MoreLars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin. Source link
Read MoreThe FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer's treatment's
Read MoreSome Wall Street analysts said Viking's experimental obesity treatment may be "best-in-class" following the release of midstage trial data. Source
Read More